Attention AACR Annual Meeting 2017 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Educational Session 2: PI3K and MEK Pathway Inhibitors

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3
BRAF and RAS signaling in melanoma: From basic biology to clinical exploitation
Richard M. Marais
Cancer Research UK Manchester Institute, Manchester, United Kingdom
from 2013 Molecular Targets and Cancer Therapeutics conference on October 19, 2013 4:45 PM-6:15 PM
Title to be announced
Neal Rosen
Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 19, 2013 4:45 PM-6:15 PM
Matrix-dependent adaptive resistance to targeted therapy
Joan S. Brugge
Harvard Medical School, Boston, MA, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 19, 2013 4:45 PM-6:15 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3